In menopause-related moderate-to-severe vasomotor symptoms not suitable for hormone therapy, fezolinetant safely improved symptoms.
Where this comes from
- Record sourced from PubMed, PMID 40163868.
- Also identified by DOI 10.7326/ANNALS-25-00829-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text].